The syndrome of multiple endocrine neoplasia type 2B (MEN 2B) resembles that of MEN 2A in that both include medullary carcinoma of the thyroid, pheochromocytoma, and autosomal dominant inheritance, but is distinct in that MEN 2B patients have neuromas of the mucous membranes. MENBA has been linked to RBP3, DlOS5, FNRB, DlOS15, and DlOZl near the centromere of chromosome 10. We examined linkage between MENBB and RFLPs on chromosome 10 in all available members in two or three generations of 14 kindreds. The centromere marker DlOZl was linked to MENBB with a peak lod score of 5.42 at 8 = 0.02. One possible recombinant was observed between DlOZl and MENPB. Multipoint analysis of RFLPs at FNRB, DlOZl, RBP3, and DlOS15 gave a peak lod score of 7.12 at the midpoint between DlOZl and RBP3 on the long arm (band qll).
The most likely gene order FNRB-DlOZl-MENSB was 27 times more likely than MENZB-FNRB-DlOZl and 34 times more likely than FNRB-MENZB-DlOZl. Additional data will be required to establish the order of these loci with confidence. o isso
INTRODUCTION
Multiple endocrine neoplasia type 2B (MEN 2B) is a syndrome of medullary carcinoma of the thyroid gland (MTC), tumors of the medulla of the adrenal gland, and neuromas of the oral mucosa and is inherited as an autosomal dominant trait. The gene for a similar syndrome of multiple endocrine neoplasia, type 2A (MEN 2A), has been located in the pericentromeric area of chromosome 10 by linkage to several 1 To whom correspondence should be addressed.
restriction fragment length polymorphisms (RFLPs) (Mathew et al., 1987; Simpson et al., 1987; Sob01 et al., 1988 Sob01 et al., , 1989a Nakamura et al., 1989; Yamamoto et al., 1989; Wu et al., 1990) . MEN 2B is distinguished from MEN 2A by the presence in MEN 2B of the mucosal neuromas, earlier onset and faster growth of the thyroid cancers, and often skeletal abnormalities including the Marfanoid habitus with arachnodactyly (Williams and Pollack, 1966; Gorlin and Mirkin, 1972; Khairi et al., 1975; Carney et al., 1976; Jones and Sisson, 1983; Jackson et al., 1984 
Families
Fourteen kindreds with MEN 2B were examined (Fig. 1) . Each of the 44 affected individuals in these kindreds had the bumpy lips and/or tongue typical of the oral mucosal neuromas seen in MEN 2B (Williams and Pollock, 1966; Gorlin and Mirkin, 1972; Khairi et al., 1975; Carney et al., 1976) . Each had had proven medullary thyroid cancer except for two obviously affected individuals: a newborn girl in pedigree 4 with bumpy lips and feeding difficulties, and a man in pedigree 10 who had refused surgery for his thyroid enlargement although pheochromocytomas had been removed. Nineteen of the 44 had pheochromocytomas and/or adrenal medullary hyperplasia. Pedigree 1 (O'Neal, 1983 ), pedigree 5 (Khairi et al., 1975 , pedigree 8 (Eyer et al., 1988 ), pedigree 11 (Sob01 et,& 1989b , and pedigree 13 (Kullberg and Nieuwenhuijzen have been reported. In pedigree 5, the younger affected male was examined at age 6 and reported (Khairi et al., 1975) to have no mucosal neuromas and normal catecholamines in plasma and urine. Although his mother had noticed in infancy the characteristic lip changes that she had noted in his older sister and brother, his thyroid was not removed until age 9. On examination at age 20 he also had definite mucosal neuromas of the tongue.
DNA Markers and Gemtyping
DNA was extracted from peripheral blood (Gustafson et al., 1987) and digested with restriction enzymes as recommended by the suppliers. Agarose electrophoresis was performed as described (Devilee et aZ., 1988) , except that Tris-borate buffer replaced Tris-acetate buffer. Fragments were blotted on Nytran filters and hybridized with a probe for DlOZl as described (Devilee et aZ., 1988) or with probes for the other RFLPs as described (Meinkoth and Wahl, 1984 of missing individuals relevant to analysis of linkage to MENBB could not be inferred from the genotypes of the offspring or parents without reference to population allele frequencies in four instances (deceased spouse in pedigree 5, at DlOS5; the mother in pedigree 12 at DlOS15; the father in pedigree 13 at DlOS15; the mother in pedigree 14 at DlOS15).
For analysis of these pedigrees the population frequency of the ToqI RFLP at DlOS5 was from Simpson et aE. (1987) , and the frequencies of three alleles at the DlOS15 RFLP with either RsaI or MspI were 0.79,0.12, and 0.09. The frequency used for the MENBB gene was 0.0001, and the mutation rate assumed at this locus was 0.00001. The fraction of MENBB carriers manifesting any aspect of the syndrome was assumed to be 80% between birth and age 5 and 99% over age 5. The rarity of MENBB has prevented observations that would provide estimate.s of age-of-onset of the accuracy available in MENBA provided by Gage1 et al. (1982) .
For multipoint analysis the-distances between loci used were from Wu et al. (1996) . Because the multipoint analysis of all the pedigrees exceeded the capacity of our computer, pedigrees l-10 ( Fig. 1) were analyzed as one group, and pedigrees 11-14 were analyzed as a second group. The lod scores from the two groups were added at each recombination fraction. Table 1 shows the results of analysis of linkage between MENBB and DNA markers. These pairwise results indicate that MENBB is linked to DlOZl (with a lod score of 5.42 at fl = 0.02 and a l-lod confidence interval of o-0.13) but is not closely linked to DlOS24 on the short arm. The results are only slightly positive for linkage to RBP3 but strongly positive for linkage to DlOS15 (which is tightly linked to RBP3) because RBP3 was informative for a probable recombinant with MEN2B but not informative in several other off- (Fig. 2) which shows the peak lod score of 7.12 at the midpoint between DlOZl and RBP3. Our results with MEN2B compared with a multipoint map of MENBA (Wu et al., 1990) show overlapping confidence limits. The 1-lod confidence interval for MENBB extends from DlOZl9 CM on the q arm to 6 CM on the p arm in the female map. The most likely gene order FNRB-DlOZl-MEN2B was 27 times more likely than MEN2B-FNRB-DlOZl and 3: times more likely than FNRB-MENBB-DlOZl.
RESULTS
Additional data will be required to establish the order of these loci with confidence.
A possible crossover in pedigree 2 between MENBB and both DlOZl and FNRB provides evidence that MENBB lies on the long arm flanked by DlOZl and RBP3/MCK2.
This involved an unaffected 8$yearold male who shows none of the phenotypic features of MENBB which his mother and two brothers mani- fested at a much earlier age. Additionally, strong evidence for his unaffected status is provided by a recent unequivocally negative pentagastrin-stimulated calcitonin test for MTC. This result effectively excludes MTC, which is present and often metastatic in MENBB patients by age 4 (Jones and Sisson, 1983) . A single crossover between RBP3, DlOS15, and DlOS5 on one side and MENOB, DlOZl, FNRB, and DlOS24 on the other side probably occurred in pedigree 1 (Fig.  1) . This resulted in different DNA marker types in two people who have MENBB and thus is unlikely to be an artifact of misclassification of MENBB genotype. In both of these possible crossovers the phase in the affected parent is unknown, so the lod scores for linkage at the marker are not strongly negative. The locations of the probes used are shown on the physical map of chromosome 10 (Fig. 3) modified from Smith and Simpson (1989) . Sob01 et al., 1989b) , is closely linked to the same DNA markers near the centromere of chromosome 10 to which MENBA has been linked and suggest a close relationship of the similar syndromes but do not establish allelism of the genes.
This study illustrates well the dependence of gene localization on the accurate identification of affected individuals on the basis of clinical data. If the crossover male in pedigree 2 (Fig. 1) ized to the proximal long arm of chromosome 10 by studies of this one family. Although our clinical experience has shown that the diagnosis of MENBB can be made in early childhood by observation of the mucosal neuromas by experienced parents and/or physicians and by conversion of negative to positive pentagastrin-stimulated calcitonin testing for the thyroid cancer by age 5, insufficient data on this rare disease are available at present to exclude all doubt. Although these findings are compatible with the contiguous gene theory for tumors of the syndromes (Jackson et al., 1989; Jackson and Norum 1989) , further evidence of the nature of the actual genes involved is needed. The evidence for the genes for MEN 2A and MEN 2B being located close to each other would suggest that MEN 2B is probably a better term for the mucosal neuroma phenotype than the MEN 3 terminology suggested by Khairi et al. (1975) , even though that terminology did emphasize that they were separate genetic entities. These findings suggest that studies of the gene for either MEN 2 syndrome may contribute knowledge of the gene for the other syndrome. 1.
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